Meeting Report

Other Solid Cancers: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Elizabeth S. Waxman,(1) RN, MSN, AOCN®, ANP-BC, and Abby Fuoto,(2) DNP, ANP-BC, AOCNP®, ACHPN

(1) MD Anderson Cancer Center; (2) University of Arizona Cancer Center


J Adv Pract Oncol 2020;11(6):612-615 | https://doi.org/10.6004/jadpro.2020.11.6.9 | © 2020 Harborside™


  

ABSTRACT

Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, of MD Anderson Cancer Center, evaluates a study showing activity by pralsetinib in patients with a variety of tumors harboring RET gene fusions, and Abby Fuoto, DNP, ANP-BC, AOCNP®, ACHPN, of University of Arizona Cancer Center, comments on the effect of deintensification in patients with intermediate-risk HPV-positive oropharyngeal cancer. Meeting coverage is provided by The ASCO Post.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.